Table 1. The advantages and disadvantages of the various methods used to determine subcellular localisation of a radionuclide or radiopharmaceutical.
Characteristics & suitability | Subcellular fractionation | Fluorescence imaging | Micro-autoradiography | Laser ablation – ICP-MS | Ion beam analysis | X-ray fluorescence microscopy |
---|---|---|---|---|---|---|
Easy availability | Yes | Yes | No | No | No | No |
Cheap | Yes | Yes | No | No | No | No |
Easy sample preparation | Yes | Yes (once dual labelled radiopharmaceutical synthesized) | No | Possibly (depends on sample) | No | No |
Resolution | N/A | <1 μm | 10–120 μm | >1 μm | 0.2–2 μm | 50 nm |
Sensitivity | N/A | Depends on fluorophore and microscope | Depends on radionuclide and sample preparation | ppt; pg/mL | ppm; pg/mL | ppb; ng/mL |
2D or 3D | N/A | 2D and 3D | 2D and 3D | 2D and 3D (if combinedwith other methods) | 3D | 2D and 3D |
Unchelated radionuclide | No | No | Possibly | Yes (cold equivalent) | Yes (cold equivalent) | Yes (cold equivalent) |
Chelated | radiopharmaceutical | Yes | Yes | Yes | Yes (cold equivalent) | |
Yes (cold equivalent) | Yes (cold equivalent) |